PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Filter page content by community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Madopar, Prolopa, Prolopa 100/25, Prolopa 200/50
Generic Name: Levodopa and benserazide

What is Levodopa and benserazide? Levodopa is the precursor molecule to dopamine, an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide is an additive which allows the levodopa to continue circulating in the body for longer.


Reasons Taken

19 patients in the community are taking or have taken Levodopa and benserazide.

Reason # Patients Percentage of patients
Treat Parkinson's 15 78%
Other 2 10%
Slowness 1 5%
Stiffness/spasticity 1 5%

Dosages

Based on the patients currently taking Levodopa and benserazide.

Top 10 (Show all)

All (Show Top 10)

  0 mg none 2 mg day 25 mg day 50 mg day 125 mg day 375 mg day 400 mg day 425 mg day 500 mg day 750 mg day 1087.5 mg day 1550 mg day
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Levodopa and benserazide or how long patients were taking Levodopa and benserazide before stopping.

Currently taking Levodopa and benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
6

Stopped taking Levodopa and benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
0
Why Patients Stopped Taking Levodopa and benserazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1 50% Other: 50%
Not indicated 1 50% Not indicated: 50%

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 50% 1
Moderate 50% 1

Treat Parkinson's

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 2

Top reported side-effects include:

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 2)

  • asb
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: mild
    See profile
  • asb
  • by asb
    Sep 14, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
results have varied a lot; the dose has been upped several times over 3 years

See all evaluation results for Levodopa and benserazide



Back to top